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background: Some pediatric patients referred for heart transplant (Htx) evaluation are not suitable candidates for Htx. The outcomes of such 
patients are presumed to be dismal, but are not well described. Information about the destiny of these children may help with decision-making 
regarding alternative therapies, such as palliative surgery or high risk Htx.
Methods: We retrospectively reviewed all referrals for Htx evaluation from January 2005 to July 2013. We excluded those who were listed for Htx, 
or who were denied Htx due to being “too well”. Endpoints included mortality and length of survival. We censored our follow-up data at last physician 
contact.
results: Of 212 referrals, 39 (19%) (age 6 wk to 19 yr, median 3.5 yr) were denied Htx candidacy for reasons other than being too well. 28 (72%) 
had palliated congenital heart disease. 21 (54%) were inpatients, of which 9 (23%) were intubated and 16 (41%) were inotrope dependent. 19 
(49%) were NYHA Class IV, 20 (51%) were class II-III. There were 15 mortalities (38%) with median follow up time of 195 days (8-2832 days). 
10 patients received a subsequent cardiac surgery with one mortality (10%) and median follow-up of 2.6 yr (fenestrated Fontan, AV valve repair, 
conversion to 2-ventricle circulation, Ross procedure, coronary artery repair, BT shunt). Survival for 13 highly presensitized patients was 46% with 
median follow up of 148 days. Mortality was increased for those who were mechanically ventilated (78% vs. 27% p = 0.0002), inotrope-dependent 
(56% vs 26% p=0.002), and for inpatient Htx (48% vs. 28% p=0.03). Males also had higher mortality (57% vs. 22% p = 0.02). Mortality risk was not 
influenced by age, weight, growth failure, congenital heart disease, or single ventricle physiology.
conclusion: An advanced heart failure program can achieve satisfactory results for pediatric patients who are not suitable candidates for Htx. 
Some children may benefit from high-risk palliative surgery, sometimes exceeding expectations of a high-risk Htx. Inpatients, particularly those who 
are NYHA class IV, mechanically ventilated, and/or inotrope dependent at Htx referral are at particularly high risk of dying and may still benefit from 
consideration of high risk Htx.
